Methodist Hospital Cardiac Catheterization Report
|
|
- Mitchell Dorsey
- 6 years ago
- Views:
Transcription
1 Methodist Hospital Cardiac Catheterization Report Patient Name: Diaz, John R Patient ID: RH Study Date: 6/6/2016 Gender: M Priority: ROUTINE Height: 68.9 in BP: 145/82 DOB, Age: 11/8/1953, 62 yr Weight: lb HR: 89 BSA: 1.95 m² Inpatient History/Clinical: Abdominal aortic aneurysm, Congestive failure, Congestive cardiomyopathy, COPD Procedure: Trancatheter Aortic Valve Replacement (TAVR) Previous Study: Date: 03/31/2016 Stage 1 AO LV RA RV MPA RPA 19 PCW AO AODsc SVC IVC 76 RA 78 RAHi 78 RALo 77 MPA 78 Shunts & Resistances Qs 3.4 l/min Qs I 1.74 l/min/m² Rs (WU) Rs I (WU) 78% 76% 15/ % 15/ / / / / /10 13 HR 80 bpm Hgb 13.2 g/dl VO2 128 ml/min VO2 I ml/min/m² CAo % CVo2 77 % PAo2 78 % O2cap ml O2/l SAC ml O2/l SAC diss O ml O2/l MVC ml O2/l MVC diss O ml O2/l PAC diss O ml O2/l Fick CO 3.4 l/min Fick CI 1.74 l/min/m² Critical Aortic Valve Stenosis Pre Procedure. Valve Areas / Gradients Peak Mean Areas (mmhg) (mmhg) (cm²) AV Arterial Blood Gases ph 7.3 PaO2 93 mmhg PaCO2 32 mmhg HCO meq/l BE -0.9 meq/l Cath Lab Report Page 1
2 Stage 2 AO LV MPA PCW HR 85 bpm Hgb 13.2 g/dl VO2 175 ml/min VO2 I ml/min/m² CAo2 98 % CVo2 78 % O2cap ml O2/l SAC ml O2/l MVC ml O2/l Fick CO 4.87 l/min Fick CI 2.5 l/min/m² AO 98 SVC 78 Valve Areas / Gradients Peak Mean Areas (mmhg) (mmhg) (cm²) AV Shunts & Resistances Qs 4.87 l/min Qs I 2.5 l/min/m² Catheterization Report TAVR Percutaneous The patient is a(n) 62 yr old Hispanic male. Cardiac/Peripheral Indications : Cardiac Cath Status: Elective. Heart failure was cited as a reason for the diagnostic cath procedure. The patient has a history, physical findings, or noninvasive evidence of valvular heart disease. Two cardiac surgeons have independently examined the patient face-to-face to determine the patient's suitability for the procedure. The patient is under care of the heart team. It is furnished in a hospital with appropriate infrastructure for this procedure. The heart team and hospital are participating in a prospective, national, audited registry. The patient is not an operative candidate and has critical/severe aortic stenosis. The patient has congestive heart failure. Consents/Checklists: The patient verbally verified their identification when possible. The patient was identified by hospital ID band. Informed consent was obtained from patient or family, as appropriate. The procedure indications, including possible risks, outcomes, benefits and alternative treatment(s) have been explained to the patient and/or legal guardian/surrogate at length by the performing physician. The patient or family, as appropriate, consents to the sedation plan, alternatives, and risks including the need for possible resuscitation. The patient has been reevaluated immediately before the procedure and is still fit for the planned sedation and procedure. The history and physical paperwork has been obtained. The patient has had an EKG. The patient or family, as appropriate, verbalized understanding of procedure. A pre-procedure "Time Out" was performed. All team members, including physician are present. Verification of the patient's identity, utilizing the double identifiers (Name and DOB) has been accomplished. Agreement on the procedure to be performed has been accomplished. Procedure: The left femoral artery was catheterized using a percutaneous technique. A 8 Fr. sheath was placed in the artery. The arterial sheath was sized up to 11 Fr. The right femoral vein was catheterized using a percutaneous technique. A 6 Fr. sheath was placed in the vein. The patient was brought to the operating room and placed upon the OR table in a supine position. The patient underwent an uneventful induction of general anesthesia, and endotracheal intubation performed by the cardiac anesthesiologist. All pressure points were carefully and appropriately padded. Perioperative antibiotics were administered in a timely fashion. Swan-Ganz catheter and radial arterial line were inserted. TEE was performed by non-invasive cardiologist. The aortic valve annulus was measured at 24 mm. There was critical aortic stenosis and mild aortic regurgitation. The patient has a New York Heart Association (NYHA) functional class of 4. The patient was now broadly prepped and draped in a normal sterile fashion from the chin to the bilateral ankles. The left common femoral artery and vein were accessed percutaneously, and a 6 Fr. arterial and 7 Fr. venous sheath were inserted. Using the arterial sheath, a pigtail catheter was inserted around to non-coronary cusp. Through the venous
3 sheath, a transvenous pacemaker was inserted out to the apex of the right ventricular cavity. Excellent pacing and thresholds were obtained. A 14 Fr. Edwards sheath was subsequently placed in the aorta. The valvuloplasty balloon was removed and a ( )mm Sapien transcatheter heart valve was now approximately oriented and crimped onto the delivery system. Appropriate placement of the valve on the sheath was confirmed. The delivery system was now brought through the sheath over the guidewire and maneuvered around the aortic arch using a retroflexed feature. The valve was now positioned across the native aortic valve. A 28mm Edwards Sapien S3 was now crimped onto the commander delivery system. The patient remained hemodynamically stable with this in place. Appropriate positioning was obtained with a combination of Paieon, fluroscopy, aortic root injection, and TEE. Using biventricular pacing, the valve was deployed. Transesophageal echocardiogram confirmed a well-seated bioprosthetic valve. No paravalvular regurgitation was apparent. The delivery system was now removed from the patient. The guidewire was maintained across the iliofemoral system to maintain access in case of an inverted injury during sheath removal. The sheath was removed under fluoroscopic guidance back to the common iliac artery. Angiography of the iliac system distal to the balloon showed no evidence of dissection or injury. The sheath was fully removed along with the extra stiff guidewire. There was an excellent pulse distally. Repeat angiography confirmed excellent distal flow. The wound was now irrigated with warm saline and closed in layers. Staples followed by a sliver nitrate dressing was applied. The patient tolerated the operation well and was transferred to the cardiothoracic ICU in stable condition. Post-procedure, the arterial sheath was pulled and a closure device was deployed. Estimated blood loss 101 to 150 ml Post-procedure, the venous sheath was pulled and pressure was applied to the site. At the completion of the study, the catheters were removed, hemostasis was maintained, and a dressing was applied. Conclusions: The patient is an62 yrold male with a known history of hypertension, hyperlipidemia, atherosclerotic heart disease, status post multiple coronary interventions in the past, CVA with residual hemiparesis has been experiencing New York Heart Association class 3-4 symptoms of congestive heart failure. He was referred for transcatheter aortic valve replacement. All risks benefits alternatives were discussed with the patient including but not limited to death, myocardial infarction, stroke, vascular injury and need for repair, need for coronary stenting, need for transfusion,need for permanent pacemaker, valve embolization and paravalvular leak requiring multiple valves as well as infection and renal failure. The patient family understood this completely. The procedure was to be performed under conscious sedation. Arterial access was obtained via the left femoral artery and 2 Perclose's were deployed. An 11 Fr. sheath was placed and was sized up to a 14 Fr. Edwards E sheath. In the distal left femoral artery a 7 Fr. sheath was placed. Via the 14 Fr. Edwards E sheath the native valve was crossed using an AL-1 catheter and a Lunderquist wire was placed in the ventricle. Over the Lunderquist wire a 26 mm Edward's E been valve was advanced and positioned using fluoroscopic guidance. Valve was deployed while pacing at 160 bpm. There was mild-tomoderate paravalvular leak post deployment and therefore postdilatation with an additional 2cc was performed. There was trivial if any paravalvular leak noted post. The Edwards E sheath was then withdrawn to the left external iliac artery and via these 7 French sheath in the common femoral artery and a by 6 mm balloon was inflated for hemostasis as the 2 Perclose's were tied off. After prolonged dilatation at the arteriotomy site was no evidence of dissection or extravasation. There was excellent distal runoff. Patient was hemodynamically stable was transferred to the surgical ICU. The case was discussed with the patient's family. Plan: Continue medical management.the findings of the cardiac catheterization suggest that medicaltherapy is the recommended form of treatment.this patient will have a TVT Registry DataCollection Form completed and be entered into the STS/ACC TVT Registry Interpreting MD 1 Cath Procedure Description: FLTime: FLDose: CINEDose: TotalDose: IntFLTime: TotalRuns: 4 Percutaneous entry: Right Femoral artery Closure Device: Suture
4 Cath Lab Report Page 4 Complications: The patient tolerated the procedure with no complications Post Procedure Pulses Bilateral DP: 3+ Bilateral PT: 3+ Staff: Cardiac Cath Physician Tony Malone, MD Circulating Nurse Bobby Brooks, RN Interventionalist Michelle Cohen, MD Radiologic Tech Nicholas Saint, RT Scrub Staff Jeanette Williamson, RN Monitoring Staff Nicole Watts, CVT Cath Lab Report Page 4
5 Methodist Hospital Cardiac Catheterization Report Patient Name: Diaz, Johnny Patient ID: RH Study Date: 6/6/2016 Gender: M Priority: ROUTINE Height: cm BP: 138/67 DOB, Age: 11/8/2013, 2 yr Weight: kg HR: 85 BSA: 0.53 m² Outpatient Procedure: Left and Right Heart Catheterization w/wo LV Angiography, Angioplasy and Stenting of Aortic Coarctation Stage 1 AO AOAsc AODsc LV RA RV MPA RPA PCW / / / % 83/55 62 AO 98 AOAsc 98 AODsc 97 SVC 77 SVCHi 77 IVC 79 RA 77 RV 79 MPA 79 RUPV 98 Shunts & Resistances Eff Flow (Qep) 1.42 l/min (Qep) I 2.68 l/min/m² Qp 1.52 l/min Qp I 2.87 l/min/m² L-R Shunt 0.1 l/min % L-R 6.58 % Rp 3.29 (WU) Rp I 1.74 (WU) TPR 8.55 (WU) TPRI 4.53 (WU) HR 99 bpm Hgb 13.2 g/dl VO ml/min VO2 I 98 ml/min/m² CAo % CVo % PAo2 79 % PVo2 98 % O2cap ml O2/l SAC ml O2/l MVC ml O2/l. PAC PVC Fick CO Fick CI 77% 79% 15/ ml O2/l ml O2/l 1.45 l/min 2.74 l/min/m² Valve Areas / Gradients Peak Mean Areas (mmhg) (mmhg) (cm²) AV / /12 19 Arterial Blood Gases ph 7.3 PaO2 93 mmhg PaCO2 32 mmhg HCO meq/l BE -0.9 meq/l Diaz, Johnny 06/06/2016 RH Cath Lab Report Page 1
6 Diaz, Johnny 06/06/2016 RH Stage 2 AOAsc AODsc AOAsc 98 AODsc 98 SVC / /61 77 Post Coarctation Repair Stent VO ml/min VO2 I 98 ml/min/m² CAo2 98 % CVo2 78 % Situs Solitus, Levocardia. Normal (atrioventricular concordance, normally connected great arteries). Aortic arch anomalies. Coarctation of aorta (COA). Diaz, Johnny RH /8/ yr 6/6/2016 HISTORY: Diaz, Johnny is a 2 yr old M with discrete coarctation of the aorta and left ventricular hypertrophy presenting for diagnostic study and intervention. PROCEDURE: Informed consent was obtained prior to the procedure after discussing the pros and cons of all reasonable alternatives. The patient was brought to the cardiac catheterization laboratory and placed under general anesthesia by the cardiac anesthesia service. The airway was managed with an ETT. A pre-procedural time out was performed. The bilateral groins were prepped and draped in the usual sterile fashion. Access was not difficult using Sonosite. Using a modified Seldinger technique, a 5F short sheath was placed in the right femoral vein and a 4F short sheath was placed in the right femoral artery. After obtaining access, the patient was heparinized to maintain ACTs greater than 220 seconds. At the beginning of the case we performed antegrade right heart catheterization using a 5F end-hole wedge catheter and a retrograde left heart catheterization using a 4F multi-marker pigtail catheter. After obtaining baseline oximetry and hemodynamics, we performed aortic angiography in biplane projections. After imaging the coarctation, we positioned a Amplatzer SuperStiff wire in the right subclavian artery retrograde from the aorta. The arterial sheath was upsized to a 9F flex sheath and advanced across the coarctation into the distal aortic arch. A 36mm Max LD stent was hand-mounted onto a 16-4 Balloon-in-balloon (BIB) catheter. The stent was advanced to the end of the long Diaz, Johnny 06/06/2016 RH
7 Diaz, Johnny 06/06/2016 RH arterial sheath and positioned at the level of the coarctation. The stent was uncovered without difficulty and the position was confirmed with small hand injections through the long sheath. The inner balloon was inflated to [5 atm] and position was again confirmed by small hand injection. The outer balloon was inflated to 6 atm and the stent was fully deployed across the coarctation. Due to residual narrowing at the mid-portion of the stent, we performed post-dilation using a 18-2 Atlas Gold. A cut pigtail catheter was then advanced across the coarctation and pressures were measured above and below the stent simultaneously. The wire was removed and a final angiogram was performed through the cut pigtail. At the end of the case, ropivacaine was infused for additional analgesia. Sheaths were pulled and hemostasis was obtained by manual pressure. There was no hematoma and no pulse loss. The patient was extubated in the cath lab and transferred to the cath recovery unit in stable condition. Complications: none. Total fluoroscopy time: 10 min Total contrast used: 20 ml Estimated Blood Loss: 20 ml Angiography a. A 3D rotational angiography was performed with a power injection in the ascending aorta with RV pacing. Angiography showed a mildly dilated ascending aorta with a normal transverse aorta. There is a Left aortic arch with normal branching pattern of the head and neck vessels. There is severe discrete coarctation of the distal arch with normal caliber descending aorta. There are multiple collaterals seen on this injection b. In straight AP and lateral projections, a multi-marker pigtail catheter has been advanced retrograde across the coarctation into the distal aortic arch. Power injection into the distal aortic arch demonstrate mildly dilated ascending aorta with a normal transverse aorta. There is a Left aortic arch with normal branching pattern of the head and neck vessels. There is severe discrete coarctation of the distal arch with normal caliber descending aorta. There are multiple collaterals seen on this injection. IMPRESSION: Diaz, Johnny is a 2 yr old M with discrete coarctation of the aorta and left ventricular hypertrophy presenting for diagnostic study and intervention. 1) Normal baseline cardiac index. 2) Severe juxtaductal coarctation with peak-to-peak gradient of 30 mmhg gradient. 3) Coarctation stented primarily with 36 mm Max LD and post-dilated using 18 mm Atlas Gold with significant angiographic improvement and reduction in peak-to-peak gradient to < 10mmHg. 4) No complications. Interpreting MD 1 was present throughout the entire case. cc: primary cardiologist and primary care Interpreting MD 1 Diaz, Johnny 06/06/2016 RH
Memorial Medical Center
Memorial Medical Center Cardiac Catheterization Report Patient Name: Diaz, John R Study Date: 3/31/2016 Gender: M Height: 68.9 in BP: 135/72 Weight: 175 lb BSA: 1.95 m² Inpatient History/Clinical: Chest
More informationEdwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved
Transcatheter Aortic Valve Replacement Symptomatic Aortic Stenosis Asymptomatic Juan Crestanello, MD Interim Director, Division of Cardiac Surgery Associate Professor Division of Cardiac Surgery The Ohio
More informationCoA Stenting Alexandria Experience
CoA Stenting Alexandria Experience By Hani Mahmoud Adel, M.D Alexandria University 2/27/2017 CE 2017 Cairo 1 Coarctation of the aorta is the eighth most common form of congenital heart disease & accounts
More information2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route
Transcatheter Aortic Valve Implantation Asian perspective Speakers s name: Paul Chiam Paul TL Chiam MBBS, MRCP, FACC I have the following potential conflicts of interest to report: NONE Consultant National
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant INDICATION: Abdominal aortic aneurysm. INTERVENTIONAL RADIOLOGIST:
More informationIntro: Slide 1. Slide 2. Slide 3. Basic understanding of interventional radiology. Gain knowledge of key terms and phrases
Slide 1 Intro: PRESENTED BY: Selena M. Moore, AAS, CCS, CPC HIMS Physician Liaison Coder This is a modified/updated presentation that was originally written by: Rosemary Waligorski, RHIT, CCS, RCC and
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant Week of June 4, 2018 Thrombolysis, Thrombectomy & Angioplasty
More informationBioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique
Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Charanjit S. Rihal MD MBA Professor and Chair Division of Cardiovascular Diseases Mayo Clinic DISCLOSURES
More informationAcute dissections of the descending thoracic aorta (Debakey
Endovascular Treatment of Acute Descending Thoracic Aortic Dissections Nimesh D. Desai, MD, PhD, and Joseph E. Bavaria, MD Acute dissections of the descending thoracic aorta (Debakey type III or Stanford
More informationPercutaneous Transapical Access for Thoracic Endovascular Repair
Percutaneous Transapical Access for Thoracic Endovascular Repair Atman P. Shah MD FACC FSCAI Co-Director, Hans Hecht Cardiac Catheterization Laboratory Clinical Director, Section of Cardiology Associate
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant Week of November 19, 2018 Abdominal Aortogram, Bilateral Runoff
More informationFirst Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always
ISPUB.COM The Internet Journal of Cardiology Volume 9 Number 2 First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not T D, J P. Citation T D, J P.. First Transfemoral
More informationINTEGRATING ECHOCARDIOGRAPHY WITH CATHETER INTERVENTIONS FOR CONGENITAL HEART DISEASE. Krishna Kumar SevenHills Hospital, Mumbai, India
INTEGRATING ECHOCARDIOGRAPHY WITH CATHETER INTERVENTIONS FOR CONGENITAL HEART DISEASE Krishna Kumar SevenHills Hospital, Mumbai, India Why talk about it? What is the big deal? Are we not stating the obvious?
More informationHybrid Muscular VSD Closure in Small Weight Children
Hybrid Muscular VSD Closure in Small Weight Children Shakeel A Qureshi, on behalf of: John P. Cheatham, MD George H. Dunlap Endowed Chair in Interventional Cardiology Director Cardiac Catheterization &
More informationTechnique. Technique. Technique. Monitoring 1. Local anesthetic? Aseptic technique Hyper-extend (if radial)
Critical Care Monitoring Hemodynamic Monitoring Arterial Blood Pressure Cannulate artery Uses 2 Technique Sites Locate artery, prep 3 1 Technique Local anesthetic? Aseptic technique Hyper-extend (if radial)
More informationTAVR: It s a Career, Not Just a Procedure! Jeffrey A Southard, MD Cardiology May 5, 2012
TAVR: It s a Career, Not Just a Procedure! Jeffrey A Southard, MD Cardiology May 5, 2012 Transcatheter Aortic Valve Replacement T- eam A- pproach to V- alve R- eplacement UCDMC Team Administration Cardiology
More informationMinimalist Transcatheter Aortic Valve Replacement (MA-TAVR)
Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR) Jensen HA, Condado JF, Devireddy C, Binongo JN, Leshnower BG, Babaliaros V, Sarin EL, Lerakis S, Guyton RA, Stewart JP, Syed AQ, Mavromatis K,
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationThe catheter-based treatment of valvular disease and aortic
Access Issues in Abdominal/ Thoracic Endovascular Aortic Repair and Transcatheter Aortic Valve Replacement René Bombien, MD, PhD, and Ali Khoynezhad, MD, PhD The catheter-based treatment of valvular disease
More informationCath Lab Essentials: Basic Hemodynamics for the Cath Lab and ICU
Cath Lab Essentials: Basic Hemodynamics for the Cath Lab and ICU Ailin Barseghian El-Farra, MD, FACC Assistant Professor, Interventional Cardiology University of California, Irvine Department of Cardiology
More informationAffiliation/Financial Relationship Grant/ Research Support: Major Stock Shareholder/Equity Interest: Royalty Income: Ownership/Founder: Salary:
IMPLANTATION OF SAPIEN XT, TRANSFEMORAL TAPED CASE Gerald Yong MBBS (Hons) FRACP FSCAI Interventional Cardiologist Royal Perth Hospital Western Australia TAVI Summit 9 th Aug 2013 Disclosure Statement
More informationHemodynamic Monitoring
Perform Procedure And Interpret Results Hemodynamic Monitoring Tracheal Tube Cuff Pressure Dean R. Hess PhD RRT FAARC Hemodynamic Monitoring Cardiac Rate and Rhythm Arterial Blood Pressure Central Venous
More informationDr. Jean-Claude Laborde
Medtronic CoreValve Experience Alternative Access (Subclavian) and Technology Evolution of the Medtronic CoreValve TAVI System Dr. Jean-Claude Laborde Glenfield Hospital, Leicester, U.K. St George Hospital,
More informationPercutaneous VSD closure
Percutaneous VSD closure Gianfranco Butera San Donato Milanese - Italy Patients selection Pts having hemodynamically significant VSD Left ventricular enlargement (left ventricular overload),defined as
More informationVascular complications of embolized core valve
Vascular complications of embolized core valve Suhail Dohad, MD FACC Director of Endovascular services, Interventional Cardiology Cardiovascular Research Foundation of Southern California, CVMG Director
More informationCONGENITAL HEART DEFECTS IN ADULTS
CONGENITAL HEART DEFECTS IN ADULTS THE ROLE OF CATHETER INTERVENTIONS Mario Carminati CONGENITAL HEART DEFECTS IN ADULTS CHD in natural history CHD with post-surgical sequelae PULMONARY VALVE STENOSIS
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More informationPercutaneous Intervention for totally Occluded Coarctation Of Aorta. John Jose, Vipin Kumar, Ommen K George Dept Of Cardiology
Percutaneous Intervention for totally Occluded Coarctation Of Aorta John Jose, Vipin Kumar, Ommen K George Dept Of Cardiology Background Coarctation of aorta (CoA) forms 5-7% of congenital heart diseases
More informationTranscatheter Aortic Valve Implantation Procedure (TAVI)
Page 1 of 5 Procedure (TAVI) Introduction Aortic stenosis (AS) is a common heart valve problem associated with heart failure and death. Surgical valve repair or replacement is recommended if AS patients
More informationOptimal Techniques for Obtaining Large Caliber Arterial Access
Optimal Techniques for Obtaining Large Caliber Arterial Access Gerald Yong MBBS (Hons) FRACP FSCAI Interventional Cardiologist Royal Perth Hospital Western Australia APCASH 11 October 2014 Disclosure Statement
More informationCY2017 Hospital Outpatient: Vascular Procedure APCs and Complexity Adjustments
CY2017 Hospital Outpatient: Vascular Procedure APCs and Complexity Adjustments Comprehensive Ambulatory Payment Classifications (c-apcs) In CY2015 and in an effort to help pay providers for quality, not
More informationPatient guide: pfm Nit-Occlud PDA coil occlusion system. Catheter occlusion of. Patent Ductus Arteriosus. with the
Patient guide: Catheter occlusion of Patent Ductus Arteriosus with the pfm Nit-Occlud PDA coil occlusion system pfm Produkte für die Medizin - AG Wankelstr. 60 D - 50996 Cologne Phone: +49 (0) 2236 96
More informationAortic Valve Practice Guidelines: What Has Changed and What You Need to Know
Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts
More informationDual Arterial Access for Stenting of Aortic Coarctation in Patients with Near-Total Descending Aortic Interruption
DOI 10.1007/s40119-015-0048-9 CASE SERIES Dual Arterial Access for Stenting of Aortic Coarctation in Patients with Near-Total Descending Aortic Interruption Tahir Hamid. Syed Ibrahim Jamallulail. Bernard
More informationChapter 10: Step-by-step guide: Transfemoral Sapien S3 TAVR Omar F. Hadidi, MD, Tom C. Nguyen, MD UT Houston. Essential or Key Steps
Chapter 10: Step-by-step guide: Transfemoral Sapien S3 TAVR Omar F. Hadidi, MD, Tom C. Nguyen, MD UT Houston Essential or Key Steps Confirm transcatheter heart valve (THV) size by 3D CT and ECHO Confirm
More informationBILLING BULLETIN. Re: Interventional Cardiology. Bulletin #: 1. Date Issued: November 10, Background
BILLING BULLETIN Re: Interventional Cardiology Bulletin #: 1 Date Issued: November 10, 2016 Background This Billing Bulletin provides billing guidance when submitting claims to Manitoba Health, Seniors
More informationPeripheral and Cardiology Coder 2018
Peripheral and Cardiology Coder 2018 Cardiovascular Services and Procedures Prepared and Published By: MedLearn Publishing A Division of MedLearn Media, Inc. 445 Minnesota Street, Suite 514 St. Paul, MN
More information1-YEAR OUTCOMES FROM JOHN WEBB, MD
1-YEAR OUTCOMES FROM JOHN WEBB, MD ON BEHALF OF THE SAPIEN 3 INVESTIGATORS UNIVERSITY OF BRITISH COLUMBIA VANCOUVER, CANADA Potential conflicts of interest Speaker's name: John Webb I have the following
More informationTranscatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data
Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,
More informationSurgery Interesting Cases
Stanford Division of Vascular Surgery Interesting Cases 11/15/2010 Vascular Surgery HPI: 57yoM h/o HTN, HLD, tobacco use, anxiety, and family hx of ruptured AAA. Developed sudden onset severe abdominal
More information(EU), FACC (USA), FSCAI (USA)
How to reduce vascular complications of TAVI Paul TL Chiam MBBS (S pore), MMed, MRCP (UK), FAMS FRCP (Edin), FESC (EU), FACC (USA), FSCAI (USA) Cardiologist Mount Elizabeth Hospital Singapore Definition
More informationTranscatheter Pulmonary Valve Replacement Update on progress and outcomes
Transcatheter Pulmonary Valve Replacement Update on progress and outcomes Barry Love, MD Director, Congenital Cardiac Catheterization Laboratory Mount Sinai Medical Center New York, New York Transcatheter
More informationPre-procedural CT angiography for Transcatheter Aortic Valve Implantation: What a Radiologist Needs to Know?
Pre-procedural CT angiography for Transcatheter Aortic Valve Implantation: What a Radiologist Needs to Know? E O Dwyer, C O Brien, I Murphy, C Shortt, O Buckley Department of Radiology, AMNCH, Dublin,
More informationStructural Heart Disease: Setting the Stage for Success
Structural Heart Disease: Setting the Stage for Success Brenda McCulloch, RN MSN RCIS Cardiovascular Clinical Nurse Specialist, Interventional & Medical Cardiology Sutter Medical Center, Sacramento mccullb@sutterhealth.org
More informationLeft ventricular guidewire pacing for transcatheter aortic valve. implantation
Page 1 of 8 Left ventricular guidewire pacing for transcatheter aortic valve implantation Ênio E. Guérios, MD 1, 2, Peter Wenaweser, MD 1, Bernhard Meier, MD 1 1 Department of Cardiology, Bern University
More informationTRANSCATHETER REPLACEMENT OF THE PULMONARY VALVE (PPVI)
TRANSCATHETER REPLACEMENT OF THE PULMONARY VALVE (PPVI) BASIL D. THANOPOULOS MD, PhD Director Interventional Cardiology of CHD Euroclinic ATHENS - GREECE TRANSCATHETER REPLACEMENT OF THE PULMONARY VALVE
More information22/06/2017. Oxford City. Transcatheter aortic valve replacement 2017 guidelines. 1. First time I have heard about it. 2.
Oxford City Transcatheter aortic valve replacement 2017 guidelines Monday 19 th June Jim Newton Oxford Oxford University Hospitals NHS FT How familiar are you with TAVR? 1. First time I have heard about
More informationTAVR SPRING 2017 The evolution of TAVR
TAVR SPRING 2017 The evolution of TAVR Matthew Johnson, MD Disclosers None Evolution of the Balloon- Expandable Transcatheter Valves Cribier 2002 SAPIEN 2006 SAPIEN XT 2009 SAPIEN 3 2013 * Sheath compatibility
More informationHeart Team For TAVI Who and How?
2 nd TAVI Summit 2012, Seoul Corea Heart Team For TAVI Who and How? Alain Cribier, MD, Charles Nicolle Hospital University of Rouen, France Disclosure Edwards Lifesciences Consultant Training / proctoring
More informationI Was Too Late With Device Placement
SCAI SHOCK 2018 A Team-Based Course On Cardiogenic Shock General Session # 2 Saturday, October 13, 2018 8:39 8:51 AM Boston Park Plaza - Boston, MA I Was Too Late With Device Placement M Chadi Alraies,
More informationEVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury. Conflict of Interest. Hypotensive shock 5/5/2014. none
EVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury Bruce H. Gray, DO MSVM FSCAI Professor of Surgery/Vascular Medicine USC SOM-Greenville Greenville, South Carolina none Conflict of Interest
More informationCalculations the Cardiac Cath Lab. Thank You to: Lynn Jones RN, RCIS, FSICP Jeff Davis RCIS, FSICP Wes Todd, RCIS CardioVillage.
Calculations the Cardiac Cath Lab Thank You to: Lynn Jones RN, RCIS, FSICP Jeff Davis RCIS, FSICP Wes Todd, RCIS CardioVillage.com Disclosure Information Calculations the Cardiac Cath Lab Darren Powell,
More informationCATHETERIZATION PROTOCOL Prepared by Matthew Crystal ( )
CATHETERIZATION PROTOCOL Prepared by Matthew Crystal (2006-06-21) Cath Procedure Diagnosis: Hospitalization Requirement Blood on hold Cath Lab Fontan Yes (CCU after completion) Yes (as per OR protocols)
More informationRevision of 10/27/2017 Form #280 Page 1 of 12 PVDOMICS STUDY Clinical Center Right Heart Catheterization (RHC) Results Form #280
Revision of 10/27/2017 Form #280 Page 1 of 12 PVDOMICS STUDY Clinical Center Right Heart Catheterization (RHC) Results Form #280 Instructions: Review PVDOMICS MOP Chapter 100 prior to completing right
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant Week of October 29, 2018 Mesenteric Arteriogram & Thrombectomy/Thrombolysis
More informationTranscatheter closure of right coronary artery fistula to the right ventricle
Case Report Transcatheter closure of right coronary artery fistula to the right ventricle Abstract Coronary artery fistula (CAF) is an uncommon anomaly usually congenital but can be acquired. Although,
More informationAdult Echocardiography Examination Content Outline
Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,
More informationAn Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St.
An Update on the Edwards TAVR Results Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St. Luke s Hospital Disclosures On the speaker s bureau for Endologix, TriVascular,
More informationCP STENT. Large Diameter, Balloon Expandable Stent
CP STENT Large, Expandable CP STENT OPTIONS 12mm to Expansion 26mm to Expansion CP Matrix (number of zigs) 1.6 2.2 2.8 3.4 3.9 4.5 5 5.5 6 12 14 15 16 18 20 22 24 26 28 30 CP Details: CP is composed of
More informationNational Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5
National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION CPT Codes: 93451, 93452, 93453, 93454, 93455, 93456, 93457, 93458, 93459, 93460, 93461 LCD ID Number:
More informationTAVR: Echo Measurements Pre, Post And Intra Procedure
2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate
More informationQuick Reference Guide
Quick Reference Guide Indications for Use The AFX Endovascular AAA System is indicated for endovascular treatment in patients with AAA. The devices are indicated for patients with suitable aneurysm morphology
More information2 Brigham and Women s Hospital, Boston, MA.
Chapter 6: History of Transcatheter Aortic Valve Replacement (TAVR) Bryan Piccirillo, MD 1 ; Pinak B. Shah, MD, FACC 2 1 Brigham and Women s Heart and Vascular Center 2 Brigham and Women s Hospital, Boston,
More informationDiagnostic & Therapeutic Cardiac Catheterization Coder 2017
Diagnostic & Therapeutic Cardiac Catheterization Coder 2017 Including peripheral and cardiovascular services and procedures Prepared and Published By: MedLearn Publishing A Division of Panacea Healthcare
More informationThoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure
Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure Tilo Kölbel, MD, PhD University Heart Center Hamburg University Hospital Eppendorf Disclosure Speaker name: Tilo Kölbel, MD I
More informationTranscatheter Aortic Valve Implantation Management of risks and complications
Transcatheter Aortic Valve Implantation Management of risks and complications TAVI Summit, Seoul, Korea, Spetember 3rd, 2011 Alain Cribier University of Rouen, France Complications of TAVI Depending on
More informationCurtiss T. Stinis, M.D., F.A.C.C., F.S.C.A.I. SCRIPPS CLINIC
Avoiding and Managing Femoral Access Site Complications Curtiss T. Stinis, M.D., F.A.C.C., F.S.C.A.I. Director, Peripheral Interventions Program Director, Interventional Cardiology Fellowship Division
More informationTAVI at Liverpool Heart & Chest Hospital. National Audit of Cardiac Services in Wales Wrexham 28/11/2012
TAVI at Liverpool Heart & Chest Hospital National Audit of Cardiac Services in Wales Wrexham 28/11/2012 Mr Aung Oo FIRSTTAVI TAVI IMPLANT IN SEPTEMBER 2008 LHCH TAVI Team Cardiologists Rod Stables, Joe
More informationIndex. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of mitral leaflets, 80 Accucinch Annuloplasty system, for mitral regurgitation, 79, 94 95 Accutrak delivery system, for CoreValve
More informationCase submission for CSI Asia-Pacific Case 2
Case submission for CSI Asia-Pacific 2018- Case 2 Title Page Case category: Coarctation and ducts, valves Title: Simultaneous balloon aortic valvuloplasty with transcatheter closure of large hypertensive
More informationIncidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation
ESC Congress 2010 28 Aug 2010-01 Sep 2010 Stockholm - Sweden Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation Gian Paolo Ussia, MD Director of Interventional
More informationCardiac Valve/Structural Therapies
Property of Dr. Chad Rammohan Cardiac Valve/Structural Therapies Chad Rammohan, MD FACC Medical Director, El Camino Hospital Cardiac Catheterization Lab Director, Interventional and Structural Cardiology,
More informationAORTIC DISSECTIONS Current Management. TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida
AORTIC DISSECTIONS Current Management TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida DISCLOSURES Terumo Medtronic Cook Edwards Cryolife AORTIC
More informationHow Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min
2016 ASE State of the Art Echocardiography Course Tucson, AZ How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, 2016 11:00 11:25 PM 25 min 1 M U H A M E D S A R I Ć, M D, P H D
More informationTCTAP C-217 Bilateral Pulmonary Arterio Venus Fistula Managed by Vascular Plugs and Coil Manotosh Panja 1 1 BelleVue Clinic, India
S450 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, VOL. 65, NO. 17, SUPPL S, 2015 Case Summary. Aneurysm at LVOT is a rare complication after Bentall operation and the aneurysm may increase in size. In
More informationSuccessful percutaneous treatment of late-onset femoral pseudoaneurysm after transcatheter, aortic valve implantation procedure
Case Report Page 1 of 5 Successful percutaneous treatment of late-onset femoral pseudoaneurysm after transcatheter, aortic valve implantation procedure Murat Celik, Uygar Cagdas Yuksel Correspondence to:
More informationTRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH
TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH Available systems: Edwards (TA and TF) and Core valve. INTRODUCTION 3 4% 0f > 65 y. 30 40% of elderly denied surgery,.
More informationStreamlining a TAVR Procedure From screening to post TAVR care Hatim Al Lawati
Streamlining a TAVR Procedure From screening to post TAVR care Hatim Al Lawati Consultant Interventional Cardiology Sultan Qaboos University Hospital Muscat Oman Speaker's name: Hatim Al Lawati, SQUH -
More information1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER
Page 1 of 5 ASPIRATION CATHETER Carefully read all instructions prior to use, observe all warnings and precautions noted throughout these instructions. Failure to do so may result in complications. STERILE.
More informationCY2015 Hospital Outpatient: Endovascular Procedure APCs and Complexity Adjustments
CY2015 Hospital Outpatient: Endovascular Procedure APCs Complexity Adjustments Comprehensive Ambulatory Payment Classifications (c-apcs) CMS finalized the implementation of 25 Comprehensive APC to further
More informationDetailed Order Request Checklists for Cardiology
Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018
More informationTranscatheter procedures of the future; expanding the treatment options for patients with severe aortic stenosis
Transcatheter procedures of the future; expanding the treatment options for patients with severe aortic stenosis John Webb MD Director interventional cardiology, St Paul s Hospital McLeod Professor of
More informationNew York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo
New York Valves 2018 Patient focused evidence-based approach New York City: 6 December 2018 Antonio Colombo Speaker 7 EMO GVM Centro Cuore Columbus Milan, Italy No conflicts to report Vascular complications
More informationHow to Assess and Treat Obstructive Lesions
How to Assess and Treat Obstructive Lesions Erwin Oechslin, MD, FESC, FRCPC, Director, Congenital Cardiac Centre for Adults Peter Munk Cardiac Centre University Health Network/Toronto General Hospital
More informationAortic valve implantation using the femoral and apical access: a single center experience.
Aortic valve implantation using the femoral and apical access: a single center experience. R. Hoffmann, K. Brehmer, R. Koos, R. Autschbach, N. Marx, G. Dohmen Rainer Hoffmann, University Aachen, Germany
More informationCRT Implantation Techniques 부천세종병원순환기내과박상원
Cardiac Venous System and CRT Implantation Techniques 부천세종병원순환기내과박상원 Cardiac Resynchronization Therapy (CRT) Goal: Atrial synchronous biventricular pacing Transvenous approach for left ventricular lead
More informationUpdate on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center
Update on Percutaneous Therapies for Structural Heart Disease William Thomas MD Director of Structural Heart Program Tucson Medical Center NCVH 2014- Tucson Disclosure of Financial Interest Research: Stock
More informationPolicy Specific Section: March 30, 2012 March 7, 2013
Medical Policy Transcatheter Aortic Valve Replacement for Aortic Stenosis Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date:
More informationPercutaneous Therapy for Calcific Mitral Valve Disease
31 st Annual State of the Art Echocardiography San Diego, CA February 18, 2018 5:00 5:15 PM 15 min Percutaneous Therapy for Calcific Mitral Valve Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive
More informationFORMAL REQUEST FOR A MEDICARE NATIONAL COVERAGE DETERMINATION (NCD) Transcatheter Aortic Valve Replacement (TAVR) Procedures
The Society of Thoracic Surgeons 633 N. Saint Clair Street Floor 23 Chicago, IL 60611 American College of Cardiology Heart House 2400 N Street NW Washington DC, 20037 September 22, 2011 Louis Jacques,
More informationHow to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI
How to manage TAVI related vascular complications Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI Definition VARC-2 consensus statement Complications caused by: Wire Catheter Anything related to vascular access
More informationSuccessful Percutaneous Closure of Mitral Bioprosthetic Paravalvular Leak Using Figulla ASD Occluder
Hans R. Figulla, M.D., PhD ; Ali Hamadanchi, M.D. Medicine, Pneumology Universitity Hospital, Jena, Germany Successful Percutaneous Closure of Mitral Bioprosthetic Paravalvular Leak Using Figulla ASD Occluder
More informationTranscather Pulmonary Valve Replacement Using The Melody Valve: Indications, Techniques, Outcomes
Transcather Pulmonary Valve Replacement Using The Melody Valve: Indications, Techniques, Outcomes Matthew J. Gillespie MD The Children s Hospital of Philadelphia SCAI Fall Fellows Course 2014 December
More informationTranscatheter aortic valve implantation (TAVI): an example of how to organise a TAVI programme
original article Transcatheter aortic valve implantation (TAVI): an example of how to organise a TAVI programme J M ten Berg R Heijmen As the population ages, aortic valve stenosis becomes more prevalent.
More informationTranscatheter Aortic Valve Replacement (TAVR)
UW MEDICINE PATIENT EDUCATION Transcatheter Aortic Valve Replacement (TAVR) Treatment for aortic stenosis This handout explains when your doctor may advise TAVR to treat aortic stenosis. It includes the
More informationArterial Map of the Thorax, Abdomen and Pelvis 2017 Edition
Arterial Map of the Thorax, Abdomen and Pelvis Angiography 75605 (-26) Aortography, thoracic 75625 (-26) Aortography, abdominal by serialography 75630 (-26) Aortography, abdominal + bilat iliofemoral 75705
More information0 P a g e NEIL E STRICKMAN MD
0 P a g e NEIL E STRICKMAN MD T ranscatheter Aortic Valve Replacement INTRODUCTION The heart is a muscular organ located in your chest between your lungs which is designed to pump blood throughout the
More informationCMR for Congenital Heart Disease
CMR for Congenital Heart Disease * Second-line tool after TTE * Strengths of CMR : tissue characterisation, comprehensive access and coverage, relatively accurate measurements of biventricular function/
More informationCoronary angiography and PCI
Coronary arteries Coronary angiography and PCI Samo Granda, Franjo Naji Department of Cardiology Clinical department of internal medicine University clinical centre Maribor Coronary arteries Atherosclerosis
More informationNew Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology
New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor Cardiothoracic Radiology Disclosure I have no disclosure pertinent to this presentation.
More information